SGMT
Sagimet Biosciences Inc.

Healthcare · Biotechnology · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

256.41M USD

Market Cap

679.98M USD

Margin of Safety

-165.2%

Intrinsic / Market Ratio

0.38×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

256.41M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

256.41M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

256.41M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

256.41M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

256.41M USD

from the sum above

Market Cap

679.98M USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.38×

the ratio the screener ranks by; Margin of Safety -165.2% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 256.41M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).

The earnings power value was not computed (a NOPAT at or below zero this year), so the value is the book value today, 256.41M USD.

Market value

Market Cap679.98M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-165.2%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 256.41M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.

The projection was not made (a profit at or below zero in the latest three years), so the value is the book value today, 256.41M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFE

Not in the value

②Equity at Year 15, Today

Not in the value

Market value

Market Cap679.98M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-165.2%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 256.41M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (an operating profit at or below zero in the latest three years), so the value is the book value today, 256.41M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap679.98M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-165.2%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 25.36%
Cost of Equity =Risk-Free Rate 4.50%+Beta 3.49×Market Risk Premium 6.00%= 25.42%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC 25.00% (default): the statements print a tax provision of 0 USD on a pretax income of -51.09M USD, which gives no rate between 0 and the profit before tax, so the 25% default stands for the tax the interest saves.

Interest Expense =EBIT -56.95M USD−Pretax Income -51.09M USD= —

The interest the company paid: EBIT is the profit before tax plus the interest.

No interest is read: it needs debt and an EBIT above the profit before tax, the gap between them being the interest. Without it the cost of debt takes the 4% default.

Cost of Debt 4.00% (default): with no debt or no interest read, the 4% default after tax stands for what the lenders are paid a year.

Debt Weight =Total Debt 1.94M USDMarket Cap + Total Debt 679.98M USD + 1.94M USD= 0.28%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 99.72%×Cost of Equity 25.42%+Debt Weight 0.28%×Cost of Debt 4.00%= 25.36%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 263.69M USD − Total Liabilities 7.28M USD = Book Value Today 256.41M USD

Total Debt 1.94M USD − Cash and Short-Term Investments 240.37M USD = Net Debt Today -238.43M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1169.8%at most 5%does not pass61,782,934 / 22,895,892
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets2.0%at least -10.0%passes(-45.70M USD − -51.09M USD) ÷ 263.69M USD
Price to bookMarket Cap ÷ Book Value Today2.65×at most 3×passes679.98M USD ÷ 256.41M USD
Operating marginOperating Income ÷ Revenue—above 10.0%not measured-56.95M USD ÷ 0 USD
Revenue growthRevenue ÷ Revenue a Year Before − 1—above 10.0%not measured0 USD / 0 USD
Net cash(Cash − Total Debt) ÷ Market Cap24.1%above -30%passes(166.06M USD − 1.94M USD) ÷ 679.98M USD
Operating efficiencyOperating Income ÷ Gross Profit—above 25.0%not measured-56.95M USD ÷ 0 USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

9.59 USD

Enterprise value

357.65M USD

the provider's own figure

EV / EBITDA

—

Price / book

2.31×

the provider's book

Price / earnings

—

Return on equity

-24.4%

the provider's figure, not this page's

Profit margin

0.0%

Revenue growth

—

Analyst target, mean

27.94 USD

Analysts

11

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

02.00M00

Gross profit

————

Operating income

-31.09M-30.77M-54.51M-56.95M

EBITDA

operating income before depreciation and amortisation

-31.09M-30.77M-54.51M-56.95M

Pretax income

-30.53M-27.90M-45.61M-51.09M

Net income

-30.53M-27.90M-45.61M-51.09M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

-30.53M-27.91M-45.61M-51.09M

R&D

24.94M19.80M38.48M39.09M
Balance sheet, year end

Total assets

33.06M96.82M160.42M116.60M

Total liabilities

220.20M5.66M4.46M5.11M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

-187.14M91.16M155.96M111.49M

Total debt

211.21K65.06K78.08K78.08K

Cash and equivalents

158.16K75.21M75.92M35.06M

Net PP&E

fixed assets after depreciation

212.21K73.07K77.08K78.08K

Working capital

current assets less current liabilities

27.54M91.08M148.47M111.41M
Cash flow

Operating cash flow

-24.51M-23.79M-42.48M-45.70M

Capital expenditure

paid out, so below zero

————

Depreciation and amortisation

————

Free cash flow

operating cash flow plus capital expenditure

-24.51M-23.79M-42.48M-45.70M